SESN2 and endometrial cancer: Further, to investigate whether the effect of SESN2 on ROS production was dependent on the mTORC1 pathway in endometrial cancer cells, we measured ROS levels using the CM-H2DCFDA probe in HEC-1A and Ishikawa cells treated with rapamycin and Torin 1.